Postmenopausal Osteoporosis
The primary cause of postmenopausal osteoporosis is the sharp decline in estrogen levels that occurs during menopause. Estrogen plays a vital role in maintaining bone strength, and its deficiency leads to accelerated bone resorption. Additional risk factors include early menopause, low body weight, family history of osteoporosis, poor calcium and vitamin D intake, smoking, alcohol use, and a sedentary lifestyle. Women with other medical conditions, such as thyroid disorders or rheumatoid arthritis, may also face increased risk.
Postmenopausal osteoporosis often remains asymptomatic until a fracture occurs. Common signs include back pain due to spinal fractures, gradual loss of height, and a stooped posture. Hip and wrist fractures are also prevalent and can result in long-term disability if not promptly treated.
Diagnosis is established through a DEXA scan, which evaluates bone mineral density and confirms the presence of osteoporosis. T-scores of -2.5 or lower are diagnostic, and additional assessments like vertebral fracture assessment (VFA) and blood tests may be used to rule out secondary causes.
Treatment involves hormone replacement therapy (HRT) for suitable women, antiresorptive medications like bisphosphonates or denosumab, and, in severe cases, anabolic agents such as teriparatide. A tailored exercise program, along with adequate calcium and vitamin D supplementation, forms the foundation of long-term management.
Preventing postmenopausal osteoporosis starts with early screening, especially for women approaching menopause. Maintaining a healthy lifestyle and addressing bone health before significant loss occurs can substantially reduce the risk of fractures and preserve quality of life.
Causes & Risk Factors
The primary cause of postmenopausal osteoporosis is estrogen deficiency following menopause. Additional risk factors include early menopause (before age 45), family history of osteoporosis, low body weight, poor calcium and vitamin D intake, smoking, physical inactivity, and the use of certain medications such as corticosteroids. Conditions like thyroid disease or rheumatoid arthritis can also contribute to bone loss in postmenopausal women.
Symptoms
The disease often progresses silently until a fracture occurs. Symptoms, when present, may include chronic back pain, a noticeable loss in height, or a stooped posture. Some women may experience spontaneous fractures in the spine or hip without any obvious trauma, which can significantly affect mobility and quality of life.
Diagnosis
Diagnosis is typically made through a DEXA scan, which measures bone mineral density and provides a T-score. A T-score of -2.5 or lower confirms osteoporosis. Risk assessment tools like the FRAX calculator may also be used to estimate the 10-year fracture risk and help guide treatment. Lab tests may be done to exclude secondary causes of bone loss.
Treatment Options
Treatment options include lifestyle measures and medication. Weight-bearing exercise, a diet rich in calcium and vitamin D, and smoking cessation are essential. Pharmacological therapies may include bisphosphonates, denosumab, or selective estrogen receptor modulators (SERMs). In severe cases, bone-building medications such as teriparatide may be prescribed. Hormone Replacement Therapy (HRT) may be considered in younger postmenopausal women without contraindications. Fall prevention strategies and home safety assessments are equally important to avoid injury.
Prevention Tips
Preventing postmenopausal osteoporosis begins with early screening, especially in the first decade after menopause. Women should ensure they meet daily calcium and vitamin D requirements, engage in regular physical activity, avoid smoking and alcohol, and consult their healthcare provider if they have additional risk factors. Proactive bone health management during midlife can significantly reduce the risk of fractures later in life.